Burkett Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
AIM
PAS
GI
PNC
CCM
FFA
CNBT
VFA
PC
SC
Burkett Financial Services's AZN Position: Q3 2026 in Review
Burkett Financial Services opened a new position in AstraZeneca (AZN) in Q3 2026: 403 shares worth $65.1K. The stake represents 0.02% of the portfolio and ranks #118 among its holdings. This is a return to the name: Burkett Financial Services previously reported a position in AZN as recently as Q4 2025.
Burkett Financial Services first reported a position in AZN in Q1 2025 and has held it in 5 quarters since. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Burkett Financial Services held 403 shares of AstraZeneca worth $65.1K as of Q3 2026.
- AstraZeneca was a new Burkett Financial Services position in Q3 2026.
- AstraZeneca made up 0.02% of Burkett Financial Services's portfolio in Q3 2026, its #118 holding.
- Burkett Financial Services first reported a position in AstraZeneca in Q1 2025 and has held it in 5 quarters since.
- 47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Burkett Financial Services's 13F filing for Q3 2026, filed 1 Oct 2026.